Robot-assisted sutureless partial nephrectomy for the treatment of fifteen bilateral renal masses in a patient with Von Hippel-Lindau syndrome: a case report from a high-volume robotic center.
Familial renal cancer
Nephron-sparing surgery
Partial Nephrectomy
Robotic surgery
Von Hippel–Lindau disease
Journal
CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
23
09
2022
accepted:
13
12
2022
medline:
2
8
2023
pubmed:
8
1
2023
entrez:
7
1
2023
Statut:
ppublish
Résumé
Renal cell carcinoma is among major causes of death in patients with Von Hippel-Lindau (VHL) syndrome, and it usually presents with multiple and bilateral lesions that may require multiple renal surgeries. This, in turn, may compromise renal function, resulting in end-stage renal disease. To minimize renal function impairment in these patients, great importance is given to the preservation of functional parenchyma with the use of nephron-sparing techniques. Furthermore, new techniques such as off-clamp surgery, selective suturing or sutureless techniques may improve long-term functional outcomes. We described the case of a 27-year-old male patient with a family history of VHL disease affected by multiple, bilateral renal masses. He received bilateral, metachronous robot-assisted partial nephrectomies (RAPN) for a total of 15 renal lesions. No intra- or post-operative complications occurred, and the patient was discharged on the second postoperative day after both procedures. Serum creatinine after the second RAPN was 0.99 mg/dl (baseline value was 1.11 mg/dl). In patients with VHL syndrome and multiple renal lesions, robot-assisted partial nephrectomy, especially with the use of clampless and sutureless techniques, helps minimizing renal function impairment and should be performed when anatomically and technically feasible.
Identifiants
pubmed: 36611089
doi: 10.1007/s13730-022-00770-7
pii: 10.1007/s13730-022-00770-7
pmc: PMC10393926
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
335-340Informations de copyright
© 2023. The Author(s) under exclusive licence to The Japan Society of Nephrology.
Références
BJU Int. 2022 Nov;130(5):671-675
pubmed: 35689414
Eur J Surg Oncol. 2019 Jul;45(7):1232-1237
pubmed: 30553632
BJU Int. 2014 Nov;114(5):741-7
pubmed: 24690155
Eur Urol. 2011 Jan;59(1):128-34
pubmed: 20971550
Int J Urol. 2019 Oct;26(10):985-991
pubmed: 31342589
J Urol. 2013 Apr;189(4):1229-35
pubmed: 23085300
Eur J Surg Oncol. 2016 Nov;42(11):1729-1735
pubmed: 27106494
J Urol. 2008 Feb;179(2):468-71; discussion 472-3
pubmed: 18076931
Eur Urol. 2019 Sep;76(3):398-403
pubmed: 31080127
Eur Urol Focus. 2022 Mar;8(2):506-513
pubmed: 33775611
J Urol. 2009 Jan;181(1):55-61; discussion 61-2
pubmed: 19012918
Urol Oncol. 2013 Aug;31(6):924-9
pubmed: 21906969
Eur Urol Focus. 2016 Dec 15;2(6):589-600
pubmed: 28723490
Eur Urol. 2008 Apr;53(4):803-9
pubmed: 18036730
Eur Urol. 2022 Feb;81(2):134-137
pubmed: 34920897
Eur J Hum Genet. 2011 Jun;19(6):617-23
pubmed: 21386872
Eur Urol. 2010 Dec;58(6):900-5
pubmed: 21414862
Eur Urol Focus. 2019 Jul;5(4):600-603
pubmed: 28869203
Ann Surg Oncol. 2011 Apr;18(4):1151-7
pubmed: 21136181
J Endocrinol Invest. 2018 Jan;41(1):21-31
pubmed: 28589383
J Med Genet. 1991 Jul;28(7):443-7
pubmed: 1895313
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Eur Urol. 2012 Dec;62(6):1097-117
pubmed: 22841673
Ann Transl Med. 2020 Feb;8(4):134
pubmed: 32175427
J Urol. 2009 Oct;182(4):1271-9
pubmed: 19683266
Eur Urol. 2014 Oct;66(4):713-9
pubmed: 24486306
Int J Urol. 2018 Sep;25(9):826-831
pubmed: 30132976
BJU Int. 2021 Dec;128 Suppl 3:30-35
pubmed: 34448346
Am J Case Rep. 2017 Nov 17;18:1220-1224
pubmed: 29146893
Ann Surg Oncol. 2016 Dec;23(13):4277-4283
pubmed: 27411552
Nat Rev Clin Oncol. 2016 Sep;13(9):537-49
pubmed: 27030075
Eur Urol. 2022 Aug;82(2):233-237
pubmed: 35568597
Eur Urol Oncol. 2021 Aug;4(4):645-650
pubmed: 32646849
Eur Urol. 2010 Sep;58(3):340-5
pubmed: 20825756
Eur Urol Focus. 2021 Mar;7(2):390-396
pubmed: 31727523
J Endourol. 2022 Mar;36(3):317-326
pubmed: 34579555